This is BrainsWay’s global website. The global website is not intended for persons in the United States and includes information on clinical indications that were not cleared by the FDA, which are subject to further US regulatory review for safety and efficacy. BrainsWay D is cleared by the FDA only for patients with MDD who failed to respond to one or more anti-depressants in the current episode, and for patients with OCD as an adjunct treatment.
Dr. Rifai is an American-Syrian physician executive and scientist and a world renowned researcher on the medical aspects of psychiatric illness. He is a recipient of the National Insitute of Mental Health Clinical Excellence Award in 2005 and the prestigious William Webb Award from the Academy of Psychosomatic Medicine in 2006. Dr. Rifai is originally from Aleppo, Syria,
Dr. Rifai’ National Research Service Award fellowship training in neuroscience was at the University of Tennessee, College of Medicine in Memphis. His residency training in Internal Medicine and Psychiatry Program was at the University of Virginia, School of Medicine. Dr. Rifai then completed further clinical fellowship training at the National Institutes of Health Clinical Center and the National Institute of Mental Health in Bethesda, Maryland.
Please fill all the marked fields